AstraZeneca CEO Pascal Soriot said the investment is a "testimony of our confidence in the U.S. economy – of the U.S.

AstraZeneca's CEO said on Tuesday that the company's China president Leon Wang, who last month was detained by Chinese ...

Despite China’s investigations into insurance fraud, allegedly illegal importation of unapproved drugs and improper ...

AstraZeneca Plc isn’t the only health-care company facing compliance questions in China as concern continued to swirl about a ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

Additionally, it will also increase its cell therapy manufacturing capacity on the West and East Coasts. Pascal Soriot, CEO ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

CEO of AstraZeneca Pascal Soriot (Justin Tallis/PA) PA Wire In its third quarter update on Tuesday, chief executive Pascal ...

“Our multibillion-dollar investment reflects the attractiveness of the business environment together with the quality of ...

Reports Q3 revenue $13.6B, consensus $13.09B. Pascal Soriot, CEO, AstraZeneca (AZN), commenting on the results said: “Our company has ...

Reports Q3 revenue $13.57B, consensus $13.09B. Reports Q3 core EPS $2.08. Pascal Soriot, CEO, AstraZeneca (AZN), said: “Our company has continued on its strong growth trajectory in the first nine ...

Alexion, and AstraZeneca Rare Disease have reported positive topline outcomes from the Phase III KOMET trial, assessing the ...